Supply shortages and insurance hurdles for GLP-1 agonists, such as Ozempic and Trulicity, have left many people with diabetes and obesity without the medicines they need to stay healthy, with drugmakers charging high prices and insurers imposing prior authorization requirements.
Tag: Novo Nordisk
Posted inNEWS
Biden and members of Congress work to reduce cost of diabetes medication for all
By Deborah Bailey, AFRO Contributing Editor Diabetes remains at the top of the list as the White House and members of Congress fight to lower prescription drug costs for all diabetic patients. For the second year in a row, President Joseph Biden used this month’s State of The Union address to emphasize his administration’s vow […]